T. Rowe Price Associates’s Orchestra BioMed OBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Sell |
438,369
-21,751
| -5% | -$58.4K | ﹤0.01% | 1912 |
|
|
2025
Q1 | $1.97M | Sell |
460,120
-27,050
| -6% | -$116K | ﹤0.01% | 1611 |
|
|
2024
Q4 | $1.95M | Sell |
487,170
-25,493
| -5% | -$102K | ﹤0.01% | 1653 |
|
|
2024
Q3 | $2.64M | Sell |
512,663
-40,040
| -7% | -$206K | ﹤0.01% | 1516 |
|
|
2024
Q2 | $4.51M | Sell |
552,703
-18,372
| -3% | -$150K | ﹤0.01% | 1249 |
|
|
2024
Q1 | $3.01M | Sell |
571,075
-51,533
| -8% | -$272K | ﹤0.01% | 1378 |
|
|
2023
Q4 | $5.69M | Sell |
622,608
-2,012
| -0.3% | -$18.4K | ﹤0.01% | 1178 |
|
|
2023
Q3 | $5.45M | Sell |
624,620
-22,837
| -4% | -$199K | ﹤0.01% | 1158 |
|
|
2023
Q2 | $4.53M | Sell |
647,457
-33,090
| -5% | -$232K | ﹤0.01% | 1210 |
|
|
2023
Q1 | $13.3M | Sell |
680,547
-5,254
| -0.8% | -$103K | ﹤0.01% | 1007 |
|
|
2022
Q4 | $6.85M | Sell |
685,801
-38,764
| -5% | -$387K | ﹤0.01% | 1119 |
|
|
2022
Q3 | $7.18M | Sell |
724,565
-2,637
| -0.4% | -$26.1K | ﹤0.01% | 1126 |
|
|
2022
Q2 | $7.24M | Sell |
727,202
-66,876
| -8% | -$666K | ﹤0.01% | 1368 |
|
|
2022
Q1 | $7.87M | Sell |
794,078
-4,605
| -0.6% | -$45.6K | ﹤0.01% | 1399 |
|
|
2021
Q4 | $7.99M | Sell |
798,683
-9,082
| -1% | -$90.8K | ﹤0.01% | 1439 |
|
|
2021
Q3 | $7.99M | Sell |
807,765
-2,373
| -0.3% | -$23.5K | ﹤0.01% | 1451 |
|
|
2021
Q2 | $8.26M | Sell |
810,138
-39,862
| -5% | -$407K | ﹤0.01% | 1437 |
|
|
2021
Q1 | $9.55M | Hold |
850,000
| – | – | ﹤0.01% | 1401 |
|
|
2020
Q4 | $10.9M | Hold |
850,000
| – | – | ﹤0.01% | 1337 |
|
|
2020
Q3 | $9.35M | Buy |
+850,000
| New | +$9.35M | ﹤0.01% | 1315 |
|